§
Luxuse
Patent Intelligence
Sign In
← Back to Patent Explorer
US7090695B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Method for treatment of mitral insufficiency

Assignee: SYNDEON AB
•
Filing: 2002-11-26
•
Granted: 2006-08-15
•
Expires: 2022-11-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for treatment of mitral annulus dilatation comprises reducing the circumference of the mitral valve annulus. The method further comprises inserting an elongate body into the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, fixing the position of the elongate body relative to the coronary sinus, and changing the shape of the elongate body in order to remodel the mitral valve annulus.

Inventors

  • 👤 Jan O Solem
  • 👤 Per O Kimblad

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 12:45
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2442; A61F2/2451; A61F2/82; A61F2/86; A61F2/90; A61F2/88; A61F2/91; A61F2/04; A61F2/06; A61F2/07; A61F2002/075; A61F2220/00; A61F2220/0008; A61F2230/00; A61F2230/0063; A61F2230/0073; A61F2230/0078

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 92 words
A device for treating mitral valve dilatation configured to be placed in the coronary sinus of a heart adjacent to the mitral valve annulus, the device comprising an elongate body made at least in part of a memory metal, wherein the elongate body is configured to asymmetrically contract after placement in the coronary sinus such that the elongate body applies a force along a portion of the atrial wall of the coronary sinus adjacent to the mitral valve annulus to press the coronary sinus against a portion of the mitral valve annulus.
Claim 2
Independent Claim 92 words
A device for treating mitral valve dilatation configured to be placed in the coronary sinus of a heart adjacent to the mitral valve annulus, the device comprising an elongate body made at least in part of a memory metal, wherein the elongate body is configured to asymmetrically contract after placement in the coronary sinus such that the elongate body applies a force along a portion of the atrial wall of the coronary sinus adjacent to the mitral valve annulus to press the coronary sinus against a portion of the mitral valve annulus.
Claim 3
Dependent Claim 37 words
The device of claim 1 wherein at least a portion of the elongate body comprises an expandable structure that expands from a collapsed condition to an expanded condition for engagement with the walls of the coronary sinus.
Claim 4
Dependent Claim 13 words
The device of claim 2 wherein the expandable structure is a stent section.
Claim 5
Dependent Claim 13 words
The device of claim 2 wherein the expandable structure is cylindrical in configuration.
Claim 6
Dependent Claim 25 words
The device of claim 1 wherein the elongate body applies the force to a plurality of portions of the atrial wall of the coronary sinus.
Claim 7
Dependent Claim 40 words
The device of claim 1 , wherein the elongate body further comprises a proximal stent section and a distal stern section and wherein the proximal and distal stent sections are expandable for engagement with the walls of the coronary sinus.
Claim 8
Dependent Claim 18 words
The device of claim 6 , wherein the proximal and distal stent sections are joined by a wire.
Claim 9
Dependent Claim 37 words
The device of claim 7 , further comprising a first eyelet fixed to the proximal stent section and a second eyelet fixed to the distal stent section, wherein the wire extends through the first and second eyelets.
Claim 10
Independent Claim 86 words
A method of treating dilatation of a mitral valve annulus including delivering a mitral valve therapy device through a venous system to a coronary sinus and deploying the device such that a distal end of the device is spaced distally from a proximal end of the device, wherein the device applies a force to a portion of an atrial wall of a coronary sinus to press the coronary sinus against a portion of the mitral valve annulus to change the shape of the mitral valve annulus.
Claim 11
Independent Claim 86 words
A method of treating dilatation of a mitral valve annulus including delivering a mitral valve therapy device through a venous system to a coronary sinus and deploying the device such that a distal end of the device is spaced distally from a proximal end of the device, wherein the device applies a force to a portion of an atrial wall of a coronary sinus to press the coronary sinus against a portion of the mitral valve annulus to change the shape of the mitral valve annulus.
Claim 12
Dependent Claim 46 words
The method of claim 9 wherein the deploying step comprises retracting a cover sheet to expose the device in the coronary sinus, the device being formed of a memory material and configured for applying the force to press the coronary sinus against the mitral valve annulus.
Claim 13
Dependent Claim 55 words
The method of claim 9 wherein the device is expandable from a collapsed condition to a deployed condition, wherein the delivering step is carried out while the device is in the collapsed condition, and wherein the deploying step further includes expanding the device after the device is delivered at least partially into the coronary sinus.
Claim 14
Dependent Claim 23 words
The method of claim 9 wherein the force is applied to a plurality of portions of the atrial wall of the coronary sinus.
Claim 15
Dependent Claim 50 words
The method of claim 12 wherein the mitral valve therapy device comprises an elongate body made at least in part of a memory material and sized for insertion into the coronary sinus, the elongate body being configured for applying the force to the plurality of portions of the coronary sinus.
Claim 16
Dependent Claim 58 words
The method of claim 13 wherein at least a portion of the elongate body is expandable from a collapsed condition to a deployed condition, wherein the delivering step is carried out while the device is in the collapsed condition, and wherein the deploying step further includes expanding the device after the device is delivered into the coronary sinus.

References Cited (Backward Citations)

US5876419A Cited
US4164046A Cited
US4655771A Cited
US4954126A Cited
US4655771B1 Cited
US4954126B1 Cited
US5061275A Cited
US5674280A Cited
US5064435A Cited
US5006106A Cited
US5170802A Cited
US5163955A Cited
US5383892A Cited
US5531779A Cited
US5919233A Cited
US5476471A Cited
US5571135A Cited
US5607444A Cited
WO1995016407A1 Cited
US5584879A Cited
US5980552A Cited
EP0727239A2 Cited
US5534007A Cited
WO1996040356A1 Cited
US5741274A Cited
US6221103B1 Cited
US20020022880A1 Cited
US20020111533A1 Cited
DE19605042A1 Cited
DE19611755A1 Cited
US6027525A Cited
US5713949A Cited
US5824071A Cited
WO1998018411A1 Cited
US5911732A Cited
US5817126A Cited
US20020124857A1 Cited
US6006122A Cited
US6203556B1 Cited
US6325826B1 Cited
US6409760B1 Cited
WO1999044534A1 Cited
WO1999053977A1 Cited
US6093203A Cited
US6250308B1 Cited
US6264602B1 Cited
US6402680B2 Cited
US20020019660A1 Cited
US6183411B1 Cited
US6402679B1 Cited
WO2000018320A1 Cited
WO2000041649A1 Cited
US6350277B1 Cited
WO2000044313A1 Cited
US6264691B1 Cited
US6669687B1 Cited
US20040133192A1 Cited
US6626899B2 Cited
WO2001000111A1 Cited
US6210432B1 Cited
WO2001050985A1 Cited
US20020016628A1 Cited
US6706065B2 Cited
US20010044568A1 Cited
US6709456B2 Cited
WO2001054618A1 Cited
US20040102841A1 Cited
US6402781B1 Cited
US6537314B2 Cited
US20020151961A1 Cited
US20040153146A1 Cited
US20020103533A1 Cited
US6248119B1 Cited
US6569198B1 Cited
WO2001085061A2 Cited
WO2001089426A1 Cited
WO2002000099A2 Cited
US6702826B2 Cited
US20020042621A1 Cited
WO2002005888A1 Cited
WO2002001999A2 Cited
US6343605B1 Cited
WO2002034118A2 Cited
WO2002053206A2 Cited
US20020087173A1 Cited
US20020103532A1 Cited
WO2002060352A1 Cited
US20020183835A1 Cited
US20020183836A1 Cited
WO2002062270A1 Cited
US6656221B2 Cited
WO2002062408A2 Cited
WO2002062263A2 Cited
WO2002096275A2 Cited
WO2002076284A2 Cited
WO2002078576A2 Cited
US20030078654A1 Cited
US20030083538A1 Cited
US20030130731A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2009-08-14 2010-02-13 2010-08-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2013-08-14 2014-02-13 2014-08-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2017-08-14 2018-02-13 2018-08-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag